Notice on Voluntary Disclosure of Polyethylene Glycol Irinotecan for the Treatment of Small Cell Lung Cancer Phase III Clinical Trials Completing the Enrollment of the First Case

SZSI · Sep 30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.